Abiraterone Acetate (Yonsa) and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Abiraterone Acetate (Yonsa) and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abiraterone
Brand name: Yonsa, Zytiga
Synonyms: Abiraterone, Abiraterone Acetate
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abiraterone Acetate (Yonsa)-Insulin degludec
- Abiraterone Acetate (Yonsa)-Insulin Degludec (U-100) Prefilled Pens
- Abiraterone Acetate (Yonsa)-Insulin Degludec (U-100) Vials
- Abiraterone Acetate (Yonsa)-Insulin Degludec (U-200) Prefilled Pens
- Abiraterone Acetate (Yonsa)-Insulin degludec and liraglutide
- Abiraterone Acetate (Yonsa)-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Abiraterone Acetate (Zytiga)
- Insulin aspart, recombinant Subcutaneous-Ablavar
- Insulin aspart, recombinant Subcutaneous-Ablysinol
- Insulin aspart, recombinant Subcutaneous-AbobotulinumtoxinA
- Insulin aspart, recombinant Subcutaneous-Abobotulinumtoxina Intramuscular
- Insulin aspart, recombinant Subcutaneous-Abraxane